Hydrokortison Tiofarma

Hydrocortisone, the active ingredient in Hydrokortison Tiofarma, is a corticosteroid presented as an oral tablet for oral use. It replaces deficient cortisol in adrenal insufficiency and reduces inflammation in a range of disorders such as allergic reactions and autoimmune conditions. It is indicated for patients with primary or secondary adrenal failure, for control of acute inflammatory episodes, and for management of severe allergic responses.

GNH USA supplies Hydrokortison Tiofarma as a licensed, GDP‑compliant international pharmaceutical supplier, providing reliable bulk shipments to hospitals, pharmacies and clinics worldwide, with adherence to EU quality standards.

Hydrocortisone is a glucocorticoid that modulates inflammatory and immune pathways, providing therapeutic benefit in several endocrine and inflammatory conditions. - Adrenal insufficiency: Restores cortisol levels, helping maintain blood pressure, metabolism and stress response. - Inflammatory disorders: Reduces tissue inflammation and swelling, improving symptoms in conditions such as arthritis or dermatitis. - Allergic reactions: Suppresses immune over‑reaction, alleviating severe allergy symptoms like hives, edema or airway inflammation.

Hydrocortisone may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Increased appetite: May lead to weight gain. - Fluid retention: Can cause mild edema. - Mood changes: Irritability or mild anxiety. - Gastrointestinal discomfort: Nausea or abdominal pain. - Skin thinning: Easy bruising or stretch marks.

Serious or Rare Side Effects: - Severe infection: Suppressed immunity may predispose to opportunistic infections. - Hyperglycemia: Elevated blood sugar, especially in diabetic patients. - Adrenal suppression: Reduced endogenous cortisol production after abrupt discontinuation. - Osteoporosis: Decreased bone mineral density with long‑term use. - Psychiatric disturbances: Psychosis or severe mood swings.

Before prescribing hydrocortisone, clinicians should evaluate several safety considerations. - Assess adrenal function: Confirm diagnosis of insufficiency before initiating therapy. - Monitor blood glucose: Check glucose levels in diabetic or at‑risk patients. - Evaluate infection risk: Use caution in patients with active infections. - Review concomitant medications: Identify drugs that may enhance corticosteroid effects. - Consider bone health: Implement calcium and vitamin D supplementation for long‑term use. - Store at ambient temperature: Keep below 25 °C in the original container, protected from moisture and light.

Hydrocortisone can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole): May increase systemic corticosteroid exposure. - Anticoagulants (warfarin): Enhanced anticoagulant effect, requiring monitoring. - Live vaccines: Immunosuppression can reduce vaccine efficacy and increase infection risk.

Moderate Interactions (Monitor Closely): - Diuretics: May exacerbate electrolyte imbalances. - Antidiabetic agents: May require dose adjustments due to hyperglycemia. - NSAIDs: Combined use can increase risk of gastrointestinal ulceration. - Antihistamines: May mask signs of adrenal crisis.